Causative Pathogens Do Not Differ between Early, Delayed or Late Fracture-Related Infections.
Journal article
Corrigan RA. et al, (2022), Antibiotics (Basel, Switzerland), 11
What Factors Affect Outcome in the Treatment of Fracture-Related Infection?
Journal article
McNally M. et al, (2022), Antibiotics (Basel, Switzerland), 11
Clinical Metagenomic Sequencing for Species Identification and Antimicrobial Resistance Prediction in Orthopedic Device Infection.
Journal article
Street TL. et al, (2022), J Clin Microbiol
Providing an Evidence Base for Tissue Sampling and Culture Interpretation in Suspected Fracture-Related Infection.
Journal article
Dudareva M. et al, (2021), J Bone Joint Surg Am
Can we predict outcome after treatment of long bone osteomyelitis?
Journal article
Hotchen AJ. et al, (2020), The bone & joint journal, 102-B, 1587 - 1596
Definition and diagnosis of fracture-related infection.
Journal article
McNally M. et al, (2020), EFORT open reviews, 5, 614 - 619
Can we predict outcome after treatment of long bone osteomyelitis?
Journal article
Hotchen AJ. et al, (2020), The bone & joint journal, 1 - 10
Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study
Journal article
Eyre DW. et al, (2020), eLife, 9
Limited diagnostic value of serum inflammatory biomarkers in the diagnosis of fracture-related infections.
Journal article
Sigmund IK. et al, (2020), The bone & joint journal, 102-B, 904 - 911
The BACH classification of long bone osteomyelitis.
Journal article
Hotchen AJ. et al, (2019), Bone & joint research, 8, 459 - 468
Osteomyelitis of the Pelvic Bones: A Multidisciplinary Approach to Treatment.
Journal article
Dudareva M. et al, (2017), Journal of bone and joint infection, 2, 184 - 193
The use of a biodegradable antibiotic-loaded calcium sulphate carrier containing tobramycin for the treatment of chronic osteomyelitis: a series of 195 cases.
Journal article
Ferguson JY. et al, (2014), The bone & joint journal, 96-B, 829 - 836
Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan Children, in the context of vaccine vector efficacy
Journal article
Dudareva M. et al, (2009), Vaccine, 27, 3501 - 3504